Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

BACKGROUND: Outcome of sirolimus-eluting stent (SES) in patients treated with an antivitamin K (VKA) agent before the PCI procedure is unknown. METHODS: A total of 7651 patients were selected among 15,147 recipients of SES, included in the worldwide e-SELECT registry, only from those centers which i...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Sabaté, M, Brugaletta, S, Abizaid, A, Banning, A, Bartorelli, A, Džavík, V, Ellis, S, Holmes, D, Gao, R, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Spaulding, C, Stoll, H, Worthley, S, Urban, P
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2013

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry nork Sabaté, M, Brugaletta, S, Abizaid, A, Banning, A, Bartorelli, A, Džavík, V, Ellis, S, Holmes, D, Gao, R, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Spaulding, C, Stoll, H, Worthley, S, Urban, P

Argitaratua 2013

Journal article

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

Antzeko izenburuak